NICE technology appraisal guidance
Issued: September 2009
TA179
Sunitinib for the treatment of gastrointestinal stromal tumours
This is an extract from the guidance and may be misleading if read alone. The complete guidance is available at guidance.nice.org.uk/ta179
Important information about this guidance
This guidance was developed using the NICE single technology appraisals process: www.nice.org.uk/aboutnice/howwework/devnicetech/developing_nice_technology_appraisals.jsp